Endothelin-1 (ET-1) is a promising biomarker for predicting BPD, as it is associated with bronchoconstriction and pulmonary hypertension, with elevated levels indicating early risk in preterm infants with nRDS (3–5). The gene discussed is EDN1; the disease is bronchopulmonary dysplasia.